Literature DB >> 8809128

T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles.

S Jurcevic1, A Hills, G Pasvol, R N Davidson, J Ivanyi, R J Wilkinson.   

Abstract

The T cell response to a mixture of eight peptides derived from sequences of the Mycobacterium tuberculosis 16-, 19- and 38-kD antigens (MTBmix-8) has been studied. The peptides were selected on the basis of complementary binding to nine HLA-DR molecules (HLA-DR1 to DR9). MTBmix-8 at 6.25 and 50 micrograms/ml gave rise to significant stimulation (P < 0.05) of peripheral blood mononuclear cells (PBMC) from healthy tuberculin-positive and both untreated and treated diseased subjects, but not in any of a control group of healthy tuberculin-negative subjects. MTB-mix-8 stimulated proliferation of PBMC from healthy tuberculin-positive individuals at lower concentrations than the individual component peptides. However, the maximal stimulation achieved was only slightly higher than that achieved with individual peptides. MTBmix-8 also stimulated the production of interferon-gamma (IFN-gamma) in vitro. Using the mean +/- 2 s.d. of the values for IFN-gamma production in the tuberculin-negative population as a cut-off, MTBmix-8 at 6.25 micrograms/ml was able to detect infection with a sensitivity of 100% in untreated patients, 87% in treated patients, and 82% in tuberculin-positive controls. The corresponding figures for the most potent single peptide (16p91-110) were: 66% in untreated patients, 71% in treated patients and only 42% in controls. Thus, using the IFN-gamma-based assay, which has the additional advantages of speed and does not require radioactivity, the mixture of peptides is more sensitive than single peptides in diagnosing infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809128      PMCID: PMC2200523          DOI: 10.1046/j.1365-2249.1996.d01-791.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods.

Authors:  Elisabeth Schölvinck; Katalin A Wilkinson; Adam O Whelan; Adrian R Martineau; Michael Levin; Robert J Wilkinson
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein.

Authors:  N Caccamo; A Barera; C Di Sano; S Meraviglia; J Ivanyi; F Hudecz; S Bosze; F Dieli; A Salerno
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kD alpha-crystallin antigen of Mycobacterium tuberculosis.

Authors:  J N Agrewala; R J Wilkinson
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

4.  Capacity of murine T cells to retain long-term responsiveness to mycobacterial antigens is controlled by the H-2 complex.

Authors:  A V Pichugin; S V Khaidukov; A M Moroz; A S Apt
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.

Authors:  S M Arend; A C Engelhard; G Groot; K de Boer; P Andersen; T H Ottenhoff; J T van Dissel
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.

Authors:  J N Agrewala; B Kumar; H Vohra
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides.

Authors:  S M Arend; A Geluk; K E van Meijgaarden; J T van Dissel; M Theisen; P Andersen; T H Ottenhoff
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle.

Authors:  H M Vordermeier; P C Cockle; A Whelan; S Rhodes; N Palmer; D Bakker; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

9.  Effect of multiple genetic polymorphisms on antigen presentation and susceptibility to Mycobacterium tuberculosis infection.

Authors:  Stewart T Chang; Jennifer J Linderman; Denise E Kirschner
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

10.  Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort.

Authors:  S W Lee; S H Lee; J-J Yim
Journal:  Infection       Date:  2012-05-15       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.